Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide 2021-04-16 18:29
Transcenta Announced Presentation of Preclinical Data of TST005 at 2021 AACR Virtual Annual Meeting 2021-04-16 08:00
Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China 2021-04-15 18:20
Adlai Nortye Announces First Patient Dosed in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma 2021-04-15 09:00
Kintor Pharmaceutical and Visum Announced Strategic Partnership to Expand Proxalutamide Manufacturing 2021-04-14 22:18
Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public 2021-04-13 19:30
Harbour BioMed Presents Novel Antibody for Cancer Immunotherapy at 2021 American Association for Cancer Research Annual Meeting 2021-04-13 14:55
PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021 2021-04-12 20:00
SkinPen® Precision Now Under Direct Management in the United Kingdom and Ireland 2021-04-12 17:32
Yiling Pharmaceutical doubled its performance through innovation in 2020 2021-04-12 17:07
Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting 2021-04-10 21:33
Bionomics Successfully Completes A$22.9 million Equity Raise 2021-04-09 18:00
Control Bionics (ASX:CBL) Partners with Numotion as Northeastern U.S. Reseller of Assistive Technology Solutions 2021-04-09 04:16
ImmVira Announces Preclinical and Clinical Data to Be Presented at the 2021 ASCO and AACR Annual Meeting 2021-04-08 20:47
Hyundai Bioscience leads in the repurposing of Niclosamide 2021-04-08 17:17
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-176 in EGFR-Mutant NSCLC with C797S 2021-04-07 06:00
MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory/Anti-Necrotic Therapy for Oral Mucositis in CCRT patients with Head and Neck Cancer 2021-04-06 20:00
Brattea, a Leading Renal Denervation Company in China, Completes over $US20 Million Series B+ Financing, led by Kuanping Capital 2021-04-06 20:00
US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002 2021-04-02 13:40
Neurophth Announces IND Approval by the NMPA for Leber Hereditary Optic Neuropathy Gene Therapy 2021-04-01 20:39
1 167 168 169 170 171 422